HIGHLIGHTS
- who: Xianxiu Ji and collaborators from the Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China have published the paper: HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF- κ B Pathway, in the Journal: BioMed Research International 1.5 of 19/07/2022
- what: This study was aimed at exploring the role of HS3ST1 in the progress of non-small-cell lung cancer (NSCLC). The authors explored the effect of HS3ST1 on SPOP expression and the occurrence and progression of NSCLC using cell lines, clinical samples . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.